All News Genetic Analysis

Equities

GEAN

NO0010692130

End-of-day quote NORDIC GROWTH MARKET Other stock markets 03:30:00 08/05/2024 am IST			5-day change	1st Jan Change
0.79 ^NOK	+41.07%		+29.51%	-7.06%

29/02	Genetic Analysis AS Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	CI
26/02	Genetic Analysis AS Announces CE-IVD Marking for its GA-map Sample Collection Kit	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Genetic Analysis AS: Notice of Annual General Meeting 2024	24/04	AQ
Genetic Analysis AS: Mandatory notification of trade - Primary Insider	19/04	AQ
Genetic Analysis AS: Publication of Annual Report 2023	18/04	AQ
Genetic Analysis AS: Mandatory notification of trade - Primary Insider	11/03	AQ
Year-end report January - December 2023	29/02	AQ
Genetic Analysis AS Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	29/02	CI
Genetic Analysis AS: Genetic Analysis AS announces CE-IVDR marking for its GA-map® Sample Collection Kit	26/02	AQ
Genetic Analysis AS Announces CE-IVD Marking for its GA-map Sample Collection Kit	26/02	CI
Genetic Analysis subsequent offering to existing shareholders has now been registered with the Norwegian Register of Business Enterprises	10/01	AQ
Genetic Analysis announces final outcome of the subsequent offering to existing shareholders	27/12	AQ
Genetic Analysis announces preliminary outcome of the subsequent offering to existing shareholders	22/12	AQ
Genetic Analysis partners up to enter the consumer market with GA-map®	21/12	AQ
Genetic Analysis Partners Up to Enter the Consumer Market with Ga-Map	21/12	CI
Genetic Analysis summarizes this year's product development activities and looks ahead to 2024	13/12	AQ
Today, the subscription period in Genetic Analysis subsequent offering begins	11/12	AQ
Genetic Analysis publishes information memorandum relating to the previously announced subsequent offering	08/12	AQ
Genetic Analysis announces final number of subscription rights received per existing share in the previously announced subsequent offering	08/12	AQ
Genetic Analysis announces terms of the previously announced subsequent offering to shareholders of up to appr. NOK 9 million	30/11	AQ
Genetic Analysis AS: Mandatory notification of trade	20/11	AQ
Genetic Analysis AS: Minutes from the Extraordinary General Meeting	20/11	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Genetic Analysis

Equities

GEAN

NO0010692130

All News

Filters